Report cover image

Global Animal Parvovirus Vaccine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 110 Pages
SKU # APRC20339483

Description

Summary

According to APO Research, The global Animal Parvovirus Vaccine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Animal Parvovirus Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Animal Parvovirus Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Animal Parvovirus Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Animal Parvovirus Vaccine include China Animal Husbandy Industry, Ringpu Bio-technology, Qilu Animal Health Products, Pulike Biological, Keqian Biology, Hile Biological, Harbin Pharmaceutical Group, DHN and Zoetis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Parvovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Parvovirus Vaccine.
The Animal Parvovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Parvovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Animal Parvovirus Vaccine Segment by Company

China Animal Husbandy Industry
Ringpu Bio-technology
Qilu Animal Health Products
Pulike Biological
Keqian Biology
Hile Biological
Harbin Pharmaceutical Group
DHN
Zoetis
Virbac
Merck Animal Health
HIPRA
Elanco
Ceva Animal Health
Boehringer Ingelheim
Bioveta
Animal Parvovirus Vaccine Segment by Type

Individual Vaccine
Combination Vaccine
Animal Parvovirus Vaccine Segment by Application

Porcine
Canine
Feline
Others
Animal Parvovirus Vaccine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Parvovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Parvovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Parvovirus Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Parvovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Animal Parvovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

110 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Animal Parvovirus Vaccine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Animal Parvovirus Vaccine Sales Estimates and Forecasts (2020-2031)
1.3 Animal Parvovirus Vaccine Market by Type
1.3.1 Individual Vaccine
1.3.2 Combination Vaccine
1.4 Global Animal Parvovirus Vaccine Market Size by Type
1.4.1 Global Animal Parvovirus Vaccine Market Size Overview by Type (2020-2031)
1.4.2 Global Animal Parvovirus Vaccine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Animal Parvovirus Vaccine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Animal Parvovirus Vaccine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Animal Parvovirus Vaccine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Animal Parvovirus Vaccine Sales Breakdown by Type (2020-2025)
1.5.4 South America Animal Parvovirus Vaccine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Animal Parvovirus Vaccine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Animal Parvovirus Vaccine Industry Trends
2.2 Animal Parvovirus Vaccine Industry Drivers
2.3 Animal Parvovirus Vaccine Industry Opportunities and Challenges
2.4 Animal Parvovirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Animal Parvovirus Vaccine Revenue (2020-2025)
3.2 Global Top Players by Animal Parvovirus Vaccine Sales (2020-2025)
3.3 Global Top Players by Animal Parvovirus Vaccine Price (2020-2025)
3.4 Global Animal Parvovirus Vaccine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Animal Parvovirus Vaccine Major Company Production Sites & Headquarters
3.6 Global Animal Parvovirus Vaccine Company, Product Type & Application
3.7 Global Animal Parvovirus Vaccine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Animal Parvovirus Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Animal Parvovirus Vaccine Players Market Share by Revenue in 2024
3.8.3 2023 Animal Parvovirus Vaccine Tier 1, Tier 2, and Tier 3
4 Animal Parvovirus Vaccine Regional Status and Outlook
4.1 Global Animal Parvovirus Vaccine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Animal Parvovirus Vaccine Historic Market Size by Region
4.2.1 Global Animal Parvovirus Vaccine Sales in Volume by Region (2020-2025)
4.2.2 Global Animal Parvovirus Vaccine Sales in Value by Region (2020-2025)
4.2.3 Global Animal Parvovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Animal Parvovirus Vaccine Forecasted Market Size by Region
4.3.1 Global Animal Parvovirus Vaccine Sales in Volume by Region (2026-2031)
4.3.2 Global Animal Parvovirus Vaccine Sales in Value by Region (2026-2031)
4.3.3 Global Animal Parvovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Animal Parvovirus Vaccine by Application
5.1 Animal Parvovirus Vaccine Market by Application
5.1.1 Porcine
5.1.2 Canine
5.1.3 Feline
5.1.4 Others
5.2 Global Animal Parvovirus Vaccine Market Size by Application
5.2.1 Global Animal Parvovirus Vaccine Market Size Overview by Application (2020-2031)
5.2.2 Global Animal Parvovirus Vaccine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Animal Parvovirus Vaccine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Animal Parvovirus Vaccine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Animal Parvovirus Vaccine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Animal Parvovirus Vaccine Sales Breakdown by Application (2020-2025)
5.3.4 South America Animal Parvovirus Vaccine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Animal Parvovirus Vaccine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 China Animal Husbandy Industry
6.1.1 China Animal Husbandy Industry Comapny Information
6.1.2 China Animal Husbandy Industry Business Overview
6.1.3 China Animal Husbandy Industry Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 China Animal Husbandy Industry Animal Parvovirus Vaccine Product Portfolio
6.1.5 China Animal Husbandy Industry Recent Developments
6.2 Ringpu Bio-technology
6.2.1 Ringpu Bio-technology Comapny Information
6.2.2 Ringpu Bio-technology Business Overview
6.2.3 Ringpu Bio-technology Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ringpu Bio-technology Animal Parvovirus Vaccine Product Portfolio
6.2.5 Ringpu Bio-technology Recent Developments
6.3 Qilu Animal Health Products
6.3.1 Qilu Animal Health Products Comapny Information
6.3.2 Qilu Animal Health Products Business Overview
6.3.3 Qilu Animal Health Products Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qilu Animal Health Products Animal Parvovirus Vaccine Product Portfolio
6.3.5 Qilu Animal Health Products Recent Developments
6.4 Pulike Biological
6.4.1 Pulike Biological Comapny Information
6.4.2 Pulike Biological Business Overview
6.4.3 Pulike Biological Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pulike Biological Animal Parvovirus Vaccine Product Portfolio
6.4.5 Pulike Biological Recent Developments
6.5 Keqian Biology
6.5.1 Keqian Biology Comapny Information
6.5.2 Keqian Biology Business Overview
6.5.3 Keqian Biology Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Keqian Biology Animal Parvovirus Vaccine Product Portfolio
6.5.5 Keqian Biology Recent Developments
6.6 Hile Biological
6.6.1 Hile Biological Comapny Information
6.6.2 Hile Biological Business Overview
6.6.3 Hile Biological Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hile Biological Animal Parvovirus Vaccine Product Portfolio
6.6.5 Hile Biological Recent Developments
6.7 Harbin Pharmaceutical Group
6.7.1 Harbin Pharmaceutical Group Comapny Information
6.7.2 Harbin Pharmaceutical Group Business Overview
6.7.3 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments
6.8 DHN
6.8.1 DHN Comapny Information
6.8.2 DHN Business Overview
6.8.3 DHN Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DHN Animal Parvovirus Vaccine Product Portfolio
6.8.5 DHN Recent Developments
6.9 Zoetis
6.9.1 Zoetis Comapny Information
6.9.2 Zoetis Business Overview
6.9.3 Zoetis Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zoetis Animal Parvovirus Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments
6.10 Virbac
6.10.1 Virbac Comapny Information
6.10.2 Virbac Business Overview
6.10.3 Virbac Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Virbac Animal Parvovirus Vaccine Product Portfolio
6.10.5 Virbac Recent Developments
6.11 Merck Animal Health
6.11.1 Merck Animal Health Comapny Information
6.11.2 Merck Animal Health Business Overview
6.11.3 Merck Animal Health Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Merck Animal Health Animal Parvovirus Vaccine Product Portfolio
6.11.5 Merck Animal Health Recent Developments
6.12 HIPRA
6.12.1 HIPRA Comapny Information
6.12.2 HIPRA Business Overview
6.12.3 HIPRA Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 HIPRA Animal Parvovirus Vaccine Product Portfolio
6.12.5 HIPRA Recent Developments
6.13 Elanco
6.13.1 Elanco Comapny Information
6.13.2 Elanco Business Overview
6.13.3 Elanco Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Elanco Animal Parvovirus Vaccine Product Portfolio
6.13.5 Elanco Recent Developments
6.14 Ceva Animal Health
6.14.1 Ceva Animal Health Comapny Information
6.14.2 Ceva Animal Health Business Overview
6.14.3 Ceva Animal Health Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ceva Animal Health Animal Parvovirus Vaccine Product Portfolio
6.14.5 Ceva Animal Health Recent Developments
6.15 Boehringer Ingelheim
6.15.1 Boehringer Ingelheim Comapny Information
6.15.2 Boehringer Ingelheim Business Overview
6.15.3 Boehringer Ingelheim Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Boehringer Ingelheim Animal Parvovirus Vaccine Product Portfolio
6.15.5 Boehringer Ingelheim Recent Developments
6.16 Bioveta
6.16.1 Bioveta Comapny Information
6.16.2 Bioveta Business Overview
6.16.3 Bioveta Animal Parvovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bioveta Animal Parvovirus Vaccine Product Portfolio
6.16.5 Bioveta Recent Developments
7 North America by Country
7.1 North America Animal Parvovirus Vaccine Sales by Country
7.1.1 North America Animal Parvovirus Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Animal Parvovirus Vaccine Sales by Country (2020-2025)
7.1.3 North America Animal Parvovirus Vaccine Sales Forecast by Country (2026-2031)
7.2 North America Animal Parvovirus Vaccine Market Size by Country
7.2.1 North America Animal Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Animal Parvovirus Vaccine Market Size by Country (2020-2025)
7.2.3 North America Animal Parvovirus Vaccine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Animal Parvovirus Vaccine Sales by Country
8.1.1 Europe Animal Parvovirus Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Animal Parvovirus Vaccine Sales by Country (2020-2025)
8.1.3 Europe Animal Parvovirus Vaccine Sales Forecast by Country (2026-2031)
8.2 Europe Animal Parvovirus Vaccine Market Size by Country
8.2.1 Europe Animal Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Animal Parvovirus Vaccine Market Size by Country (2020-2025)
8.2.3 Europe Animal Parvovirus Vaccine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Animal Parvovirus Vaccine Sales by Country
9.1.1 Asia-Pacific Animal Parvovirus Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Animal Parvovirus Vaccine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Animal Parvovirus Vaccine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Animal Parvovirus Vaccine Market Size by Country
9.2.1 Asia-Pacific Animal Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Animal Parvovirus Vaccine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Animal Parvovirus Vaccine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Animal Parvovirus Vaccine Sales by Country
10.1.1 South America Animal Parvovirus Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Animal Parvovirus Vaccine Sales by Country (2020-2025)
10.1.3 South America Animal Parvovirus Vaccine Sales Forecast by Country (2026-2031)
10.2 South America Animal Parvovirus Vaccine Market Size by Country
10.2.1 South America Animal Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Animal Parvovirus Vaccine Market Size by Country (2020-2025)
10.2.3 South America Animal Parvovirus Vaccine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Animal Parvovirus Vaccine Sales by Country
11.1.1 Middle East and Africa Animal Parvovirus Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Animal Parvovirus Vaccine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Animal Parvovirus Vaccine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Animal Parvovirus Vaccine Market Size by Country
11.2.1 Middle East and Africa Animal Parvovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Animal Parvovirus Vaccine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Animal Parvovirus Vaccine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Animal Parvovirus Vaccine Value Chain Analysis
12.1.1 Animal Parvovirus Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Animal Parvovirus Vaccine Production Mode & Process
12.2 Animal Parvovirus Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Animal Parvovirus Vaccine Distributors
12.2.3 Animal Parvovirus Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.